Cerus Corporation (CERS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $400.88M
Last updated: Nov 17, 2026 at 4:33 PM ET
Cerus Corporation (CERS) Statistics
Cerus (CERS) has a market cap of $400.88M and an enterprise value of $447.88M. Its share count is up 5.12% from a year earlier.
Total Valuation
Enterprise value is 11.72% above the market cap, as debt exceeds cash.
| Market Cap | $400.88M |
|---|---|
| Enterprise Value | $447.88M |
| Latest price (Nov 17, 2026) | $1.90 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.6x and 5.1x. Its year-end P/S ranged from 1.4x to 11.3x from 2016 to 2025.
| P/S Ratio | 1.6x |
|---|---|
| Forward P/S | 1.7x |
| P/B Ratio | 5.1x |
| P/TBV Ratio | 5.2x |
| P/FCF Ratio | 775.6x |
| P/OCF Ratio | 114.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 289.5x EBITDA and 870.7x free cash flow.
| EV / Sales | 1.9x |
|---|---|
| EV / EBITDA | 289.5x |
| EV / FCF | 870.7x |
Price Statistics
The stock is up 17.28% over 52 weeks and trades 18.45% below its 50-day average.
| Beta (1Y) | 1.68 |
|---|---|
| 52-Week Change | +17.28% |
| 1-Month Change | -14.41% |
| 3-Month Change | -33.33% |
| 6-Month Change | -29.63% |
| 5-Year Change | -65.45% |
| 10-Year Change | -52.70% |
| Total Return (1Y) | +17.28% |
| Total Return (3Y CAGR) | +2.78% |
| Total Return (5Y CAGR) | -23.34% |
| Return vs SPY (1Y) | +15.96% |
| Max Drawdown (1Y) | -43.29% |
| Max Drawdown (3Y) | -52.07% |
| Sharpe Ratio (1Y) | 0.33 |
| Correlation with SPY (1Y) | 0.31 |
| 50-Day Average | $2.33 |
| 200-Day Average | $2.43 |
| 52-Week Range | $1.47 to $3.47 |
| RSI (14 Days) | 37.1 |
| Average Volume (20 Days) | 2.54M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.96x current liabilities, and total debt is 0.84x shareholder equity.
| Current Ratio | 1.96x |
|---|---|
| Quick Ratio | 1.15x |
| Debt / Equity | 0.84x |
| Debt / EBITDA | 42.63x |
| Debt / FCF | 128.24x |
| Interest Coverage | -0.03x |
Returns and Efficiency
Return on invested capital is -0.17% over the last 12 months, against a 5-year average of -18.69%.
| Return on Equity (ROE) | -9.77% |
|---|---|
| Return on Assets (ROA) | -3.61% |
| Return on Invested Capital (ROIC) | -0.17% |
| Return on Capital Employed (ROCE) | -0.19% |
| ROE (5Y Average) | -52.16% |
| ROA (5Y Average) | -15.81% |
| ROIC (5Y Average) | -18.69% |
| Asset Turnover | 1.11x |
| Inventory Turnover | 1.67x |
| Receivables Turnover | 7.59x |
| Cash Conversion Cycle | 167 days |
Scores
CERS has an Altman Z-Score of -4.05, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -4.05 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $233.40M over the last 12 months is up 13.78% from the 12 months before.
| Revenue | $233.40M |
|---|---|
| Revenue Growth (YoY) | +13.78% |
| Gross Profit | $117.44M |
| Operating Income | -$2.47M |
| Pretax Income | -$7.02M |
| Net Income | -$7.39M |
| EBITDA | $1.49M |
| EBIT | -$236.00K |
| Reported EPS (TTM) | -$0.03 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 36.98% of the $204.73M in total assets.
| Cash and Equivalents | $16.35M |
|---|---|
| Total Debt | $63.35M |
| Net Debt | $47.00M |
| Net Debt Per Share | $0.23 |
| Working Capital | $76.56M |
| Shareholder Equity | $75.70M |
| Book Value Per Share | $0.38 |
| Tangible Book Value | $74.39M |
| Tangible Book Per Share | $0.37 |
| Total Assets | $204.73M |
| Total Liabilities | $128.37M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $3.00M of capital spending, operating cash flow left $494.00K of free cash flow.
| Operating Cash Flow | $3.50M |
|---|---|
| Capital Expenditures | $3.00M |
| Free Cash Flow | $494.00K |
| FCF Per Share | $0.00 |
| Depreciation and Amortization | $1.72M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -1.06%, against a 5-year average of -15.13%.
| Gross Margin | 50.32% |
|---|---|
| Operating Margin | -1.06% |
| Pretax Margin | -3.01% |
| Net Margin | -3.17% |
| EBITDA Margin | 0.64% |
| EBIT Margin | -0.10% |
| FCF Margin | 0.21% |
| Gross Margin (5Y Average) | 46.44% |
| Operating Margin (5Y Average) | -15.13% |
| Net Margin (5Y Average) | -18.82% |
Growth
Revenue grew 7.48% a year over 3 years.
| Revenue Growth (3Y CAGR) | +7.48% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.40% |
| Book Value Per Share Growth (2Y CAGR) | +7.27% |
| Tangible Book Per Share Growth (2Y CAGR) | +7.52% |
Dividends and Yields
CERS does not pay a dividend. Its free cash flow yield is 0.13%.
| FCF Yield | 0.13% |
|---|---|
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
Peer Position
Against 12 similar companies, CERS has the 11th highest P/S.
P/S RatioPeer median 3.2x
ROICPeer median -18.01%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.67%
| P/S Ratio | 1.6x vs 3.2x median |
|---|---|
| ROIC | -0.17% vs -18.01% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +13.78% vs +11.67% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.35% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.35% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CERS
What is CERS's market cap?
Cerus has a market cap of $400.88M. Its enterprise value, which adds debt and subtracts cash, is $447.88M.
How many shares of CERS are outstanding?
Cerus has 201.65M shares outstanding. The count is up 5.12% from a year earlier.
Does CERS pay a dividend?
No. Cerus does not pay a dividend.
How much debt does CERS have?
Cerus has $63.35M of total debt and $16.35M of cash and equivalents, a net debt position of $47.00M.
CERS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts